PMS2 and neoplasm: We therefore investigated the marker expression of MLH1, MSH2, MSH6, and PMS2; however, they were all found to be present in both mucinous carcinoma and undifferentiated lesions, indicating the mismatch repair proficiency of this tumor (Figure 6C).